Glenmark Pharmaceuticals Ltd., incorporated in the year 1977, is a Mid Cap company (having a market cap of Rs 18772.65 Crore) operating in Pharmaceuticals sector.
Financials
For the quarter ended 31-03-2021, the company reported a Consolidated Total Income of Rs 2868.39 Crore, up 2.37 % from last quarter Total Income of Rs 2801.85 Crore and up 2.02 % from last year same quarter Total Income of Rs 2811.63 Crore. Company reported net profit after tax of Rs 233.87 Crore in latest quarter.
Investment Rationale
Trending upwards on weekly frame and set to surpass its key hurdle
Promoter/FII Holdings
Promoters held 46.6 per cent stake in the company as of Dec 30, 2020, while FIIs held 30.2 per cent, DIIs 7 per cent and public and others 16.2 per cent.
(Disclaimer: Views and recommendations given in this section are the analysts’ own and do not represent those of ETMarkets.com. Please consult your financial adviser before taking any position in the stock/s mentioned.
